Concord Asset Management (Virginia)’s Gilead Sciences GILD Stock Holding History

Concord Asset Management (Virginia)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,329	Closed	-$862K	–	131
2024 Q4	$862K	Buy	9,329 +6,273	+205%	+$565K	0.19%	86
2024 Q3	$256K	Buy	3,056 +111	+4%	+$8.47K	0.06%	120
2024 Q2	$202K	Sell	2,945 -16,031	-84%	-$1.07M	0.05%	130
2024 Q1	$1.39M	Buy	18,976 +2,868	+18%	+$221K	0.37%	63
2023 Q4	$1.3M	Buy	16,108 +6,365	+65%	+$495K	0.38%	59
2023 Q3	$730K	Buy	9,743 +2,443	+33%	+$188K	0.24%	67
2023 Q2	$563K	Buy	7,300 +1,541	+27%	+$123K	0.2%	63
2023 Q1	$478K	Buy	+5,759	New	+$477K	0.2%	59

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Concord Asset Management (Virginia)'s GILD Position: Q1 2025 in Review

Concord Asset Management (Virginia) sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 9,329 shares — an estimated $862K sold.

Concord Asset Management (Virginia) first reported a position in GILD in Q1 2023 and held it in 8 quarters. The position peaked at $1.39M in Q1 2024. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

Concord Asset Management (Virginia) reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
Concord Asset Management (Virginia) sold 9,329 Gilead Sciences shares in Q1 2025, an estimated $862K.
Concord Asset Management (Virginia) first reported a position in Gilead Sciences in Q1 2023 and held it in 8 quarters.
Concord Asset Management (Virginia)'s Gilead Sciences position peaked at $1.39M in Q1 2024.
2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Concord Asset Management (Virginia)'s 13F filing for Q1 2025, filed 2 May 2025.